CLINICAL TRACK
Session III-A: New and Emerging Therapeutic Approaches for IBD

Nov 09 2017
5:10 pm - 7:00 pm

CLINICAL TRACK
Session III-A: New and Emerging Therapeutic Approaches for IBD

Co-Moderators: David T. Rubin, MD, FACG and Bruce E. Sands, MD, MS, FACG

5:10 pm

The treatment of moderate to severe IBD with anti-TNF Biologics and Immunomodulators
Gary R. Lichtenstein, MD, FACG

5:30 pm

Optimizing adhesion molecule-based therapies
Brian G. Feagan, MD, FACG

5:50 pm

Understanding the use of IL12/IL23 targeted Biologics
William J. Sandborn, MD, FACG

6:10 pm

Future IBD therapies
Silvio Danese, MD, PhD

6:30 pm

Panel discussion

7:00 pm

Adjourn and Reception